Clinical trials with over 10,000 participants showed cancer incidence rates comparable to control groups, though rodent studies identified thyroid C-cell tumors leading to FDA warnings
The emerging consensus is that bone loss is largely a side effect of rapid weight loss and reduced mechanical loading on the skeleton, though some studies suggest the drugs may also have a direct, albeit minor, biological impact on bone turnover
That's what Good Medicine Aesthetics and their staff makes every customer feel leaving their spa
More studies are needed to assess the safety and efficacy of ACV as a treatment for chronic conditions and as a dietary supplement
Although our meta-analysis also showed that GLP-1 receptor agonists did not increase the risk of thyroid cancer compared to placebo or other interventions, in combination with previously available evidence, patients at risk for thyroid cancer should be prescribed GLP-1 receptor agonists with caution
250 mV (Table 1)